PubMed Health⌕ Search

Biomedical subjects

A N Riley

Publications and source records attributed to A N Riley.

5 recordsLinked to original sources

Production of a vector to facilitate DNA mutagenesis and recombination.

Most methods for the generation of site-specific mutants and recombinant constructs require primer extension in vitro. These methods include the Kunkel method and PCR-based methods. Such methods to manipulate DNA are prone to sequence error because they take place outside the complex in vivo mechanisms that increase sequence fidelity during plasmid replication in Escherichia coli. Sequence errors are of particular concern when using PCR-based methods. We have constructed two new plasmids that facilitate the generation of site-specific mutants and recombinant constructs. The plasmids we have constructed are designed to maximize the number of unique restriction enzyme recognition sites in inserts that have been cloned into either plasmid. This was accomplished by eliminating extraneous sequence and many restriction enzyme recognition sites. New recombinant circle and recombination PCR protocols for multiplex site-specific plasmid mutagenesis were used to make these plasmids. These plasmids permit small portions of an insert sequence to be readily removed by restriction enzyme digestion. A small DNA segment, containing the targeted sequence alteration, can subsequently be ligated into a plasmid construct that has not been subjected to primer extension in vitro, diminishing the probability of encountering a sequence error and reducing the amount of DNA sequencing necessary to assess for errors.

Base Sequence↗

Controlled substances system change provides increased accountability.

The distribution and control systems for controlled substances were evaluated. A mail survey of other hospitals was conducted to obtain samples of control substance systems and the associated procedures. From these samples of existing programs and previous experiences with the current program, a system was designed to meet the needs of an 800-bed hospital with a decentralized pharmacy distribution system. The new distribution and control system completely replaced the prior system. Therefore, new forms and procedures were generated. The total system was implemented in a stepwise procedure in two-week increments over approximately 14 weeks until the entire hospital was converted. The new system has increased control as well as identified workload, inventory utilization, and problem areas.

Drug and Narcotic Control↗

Considerations for a pediatric pharmaceutical patient care service.

Pharmaceutical Patient Care Services to the ambulant pediatric patient will only be effective if special considerations are given to the patient's peculiarities. From the very young to the adolescent, each presents with special problems. Often, they cannot communicate effectively. Their health status frequently depends on the health behavior of the mother. Adolescents, in particular, present many unique medical and social problems. Pediatric patients receive fewer prescription medications than do adult patients, but drugs are administered frequently in the clinic. More often than not, nonprescription drugs are prescribed. This study could not document any particular physician concern with patient education or compliance.

Adolescent↗